1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Support from InvestNI Allows Fusion Antibodies to Develop New Technologies – PR Web (press release)

November 25, 2013Antibodiesadmin

PR Web (press release)

Support from InvestNI Allows Fusion Antibodies to Develop New Technologies
PR Web (press release)
Support from InvestNI Allows Fusion Antibodies to Develop New Technologies. Fusion Antibodies Ltd is helping to turn leading-edge research into novel drugs for the treatment of cancer and other chronic conditions with support from Invest Northern Ireland.

and more »

Post navigation

← Faith Briefs – Winnipeg Free Press Support from InvestNI Allows Fusion Antibodies to Develop New Technologies – HispanicBusiness.com →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos